首页> 外文OA文献 >Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients

【2h】

Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients

机译：循环肺斯坦 - 巴克病毒（EBV）的淋巴细胞和降低的EBV核抗原抗体反应的水平增加与固体器官移植受者的后翻转淋巴抑制性疾病的发育有关

代理获取

本网站仅为用户提供外文OA文献查询和代理获取服务，本网站没有原文。下单后我们将采用程序或人工为您竭诚获取高质量的原文，但由于OA文献来源多样且变更频繁，仍可能出现获取不到、文献不完整或与标题不符等情况，如果获取不到我们将提供退款服务。请知悉。

页面导航

著录项
引文网络
相似文献
相关主题

著录项

作者
SA Riddler; MC Breinig; JL McKnight;
展开▼
作者单位

展开▼
年度 1994
总页数
原文格式 PDF
正文语种
中图分类

相似文献

外文文献
中文文献
专利

1. Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes [J] . Thomas Mika, Roland Schroers, Katharina Strate, Frontiers in Medicine . 2019,第a期

机译：难治性Epstein-BART病毒（EBV） - 移植后的移植后淋巴抑制性疾病：通过组合的Brentuximab vEdotin和同种异体EBV特异性T淋巴细胞治愈
2. Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes [J] . Mika Thomas, Strate Katharina, Ladigan Swetlana, Frontiers in Medicine . 2019,第2期

机译：难治性Epstein-BART病毒（EBV） - 后移植后淋巴抑制性疾病：通过组合Brentuximab Vedotin和同种异体EBV特异性T淋巴细胞治愈
3. Quantitative Epstein-Barr virus (EBV) serology in lung transplant recipients with primary EBV infection and/or post-transplant lymphoproliferative disease. [J] . Verschuuren E, van der Bij W, de Boer W, Journal of Medical Virology . 2003,第2期

机译：患有原发性EBV感染和/或移植后淋巴增生性疾病的肺移植受者的定量爱泼斯坦-巴尔病毒（EBV）血清学。
4. Refractory Epstein-Barr Virus (EBV)-Related Post-transplant Lymphoproliferative Disease: Cure by Combined Brentuximab Vedotin and Allogeneic EBV-Specific T-Lymphocytes [O] . Thomas Mika, Katharina Strate, Swetlana Ladigan, 2019

机译：难治性爱泼斯坦-巴尔病毒（EBV）相关的移植后淋巴组织增生性疾病：布伦妥昔单抗Vedotin和同种异体EBV特异性T淋巴细胞联合治疗
5. Antibody Responses to Two Epstein-Barr Virus (EBV) Nuclear Antigens (EBNA-1 and EBNA-2) During EBV Primary Infection in Children Born to Mothers Infected with Human Immunodeficiency Virus [O] . L. Pedneault, N. Lapointe, C. Alfieri, 1996

机译：在为母亲的EBV原发性感染期间对两种Epstein-BARR病毒（EBN-1和EBNA-2）的抗体应对患有人类免疫缺陷病毒的母亲
6. Definition of Epstein Barr Virus (EBV)'s Role in HTLV (Human T Lymphocyte Virus-III) Infected USAF (United State Air Force) Personnel as Related to Disease Progression. [R] . Sumaya, C. V. 1989

机译：爱泼斯坦巴尔病毒（EBV）在HTLV（人类T淋巴细胞病毒-III）感染美国空军（美国空军）人员中与疾病进展相关的定义。

Increased levels of circulating Epstein-Barr virus (EBV)-infected lymphocytes and decreased EBV nuclear antigen antibody responses are associated with the development of posttransplant lymphoproliferative disease in solid-organ transplant recipients

著录项

引文网络

相似文献

相关主题

期刊订阅